Pathway Therapeutics is a biotechnology startup founded in 2008. The company received a $400.00K debt financing investment on 05 March 2013.
Pathway Therapeutics focuses on developing innovative biotechnology solutions. Despite the lack of publicly available information about their headquarters, the company has secured significant investment, signaling confidence in its potential within the biotechnology industry.